drug eluting balloon angioplasty

DEVICE3 trials

Sponsors

Medical University of Vienna, Instituto Dante Pazzanese de Cardiologia, Shanghai 10th People's Hospital

Conditions

Arterial Occlusive DiseasesArteriosclerosisAtherosclerosisCardiovascular DiseasesCritical Limb IschemiaPaclitaxelPeripheral Arterial DiseasePeripheral Vascular Diseases

Phase 1

Efficacy and Safety of Paclitaxel-eluting Balloons for Below the Knee Peripheral Arterial Disease

Shanghai 10th People's HospitalPeripheral Arterial Disease

Start: 2016-06-30End: 2017-09-30Target: 180Updated: 2016-05-13

Phase 2

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial)

Medical University of ViennaPeripheral Arterial Disease

Start: 2010-11-30End: 2012-12-31Target: 60Updated: 2010-12-09

Phase 4

Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery

CompletedNCT02212470

Instituto Dante Pazzanese de CardiologiaArterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis +6

Start: 2014-07-31End: 2019-10-31Updated: 2021-06-10

Related Papers

Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.

2016-07-0178 citations